BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- Status
- RECRUITING
- Phase
- NA
MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour
- Status
- UNKNOWN
- Phase
- PHASE1
MEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)or NF1-mutant(1b)
- Status
- SUSPENDED
- Phase
- PHASE1
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
High-Risk Skin Cancers With Atezolizumab Plus NT-I7
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
The Use of Magtrace®/Sentimag® in Sentinel Node Biopsy for Malignant Melanoma. The Magmen Study.
- Status
- COMPLETED
- Phase
- NA
An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
- Status
- UNKNOWN
- Phase
- N/A
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2